r.marsden
TL3 Regular · Granada, ES
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 11 November 2024 · last posted 1d · groups: analytical-chemists
159 posts, newest first. Showing up to 150.
-
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #7 · Analytics › Mass spectrometry · 27 Jul 2026 · 0 likes Worth separating two things that post #3 runs together. Resolution: "high resolution" commonly means
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #89 · Practice › Dosing & titration · 23 Jul 2026 · 10 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #115 · Devices › Syringes & needles · 22 Jul 2026 · 19 likes Worth separating two things that post #111 runs together. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant…
-
Which categories are strict and which are relaxed, honestly Replied, post #37 · Start Here › Welcome · 22 Jul 2026 · 14 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #118 · Outcomes › Body composition · 20 Jul 2026 · 1 like I read post #116 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #101 · Analytics › Home & field testing · 19 Jul 2026 · 21 likes Coming back to post #99, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Request: tag synonyms surfaced in search Replied, post #20 · Meta › Feature requests · 17 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Seven-day rolling means and why weekly readings mislead Replied, post #46 · Outcomes › Progress reports · 17 Jul 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #20 · Sourcing › Payments · 14 Jul 2026 · 1 like Coming back to post #18, because the follow-up matters more than the original answer. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept…
-
A site rotation scheme that is easy enough to actually follow Replied, post #105 · Practice › Administration · 4 Jul 2026 · 0 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #35 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes I read post #33 twice before replying, because I had assumed the opposite. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #88 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 0 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #27 · Evidence › Trials · 27 Jun 2026 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #47 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 16 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #63 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #16 · Analytics › Impurities & related substances · 22 Jun 2026 · 9 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
When a dose reduction is the correct response to a side effect Replied, post #31 · Practice › Dosing & titration · 20 Jun 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #115 · Practice › Reconstitution · 18 Jun 2026 · 28 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #66 · Meta › Announcements · 17 Jun 2026 · 4 likes On post #62 — agreed on the reasoning, with one qualification. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying…
-
Official shortage notices and what they authorise Replied, post #107 · Access › Shortages · 15 Jun 2026 · 0 likes I read post #105 twice before replying, because I had assumed the opposite. International supply chains: a shortage in one country does not mean shortage in another.…
-
Injection volume, overload, and peak distortion Replied, post #48 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. This is why a purity figure without the underlying chromatogram is weaker evidence…
-
What to include when your question involves a chromatogram — one year on Replied, post #34 · Start Here › How to Ask · 12 Jun 2026 · 25 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #78 · Data & Tools › Datasets · 10 Jun 2026 · 24 likes This follows post #75 rather than contradicting it. Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #11 · Pharmacology › Receptor biology · 5 Jun 2026 · 0 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Batch numbers that do not match the vial label — what changed since Replied, post #29 · Sourcing › Red flags · 4 Jun 2026 · 13 likes post #28 is right about the mechanism and I think understates the practical bit. Patterns that reliably precede a problem: underdosing (less active material than…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #11 · Compounds › Tirzepatide · 1 Jun 2026 · 26 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
The best-written scientific paper you have read Replied, post #75 · Lounge › Off topic · 31 May 2026 · 0 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #75 · Clinical › Bloodwork · 22 May 2026 · 15 likes This follows post #72 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #8 · Evidence › Meta-analyses · 21 May 2026 · 10 likes Coming back to post #6, because the follow-up matters more than the original answer. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #26 · Practice › Administration · 11 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #27 · Compounds › Tirzepatide · 6 May 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #112 · Practice › Interactions · 5 May 2026 · 0 likes Coming back to post #110, because the follow-up matters more than the original answer. Separation timing versus clinically important interaction: a separation timing…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #12 · Compounds › Tirzepatide · 1 May 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: is percentage weight change the right endpoint? Replied, post #121 · Evidence › Journal club · 30 Apr 2026 · 27 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Request: show the solution author in the topic list — what changed since Replied, post #9 · Meta › Feature requests · 30 Apr 2026 · 29 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #7 · Compounds › Tirzepatide · 28 Apr 2026 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #21 · Evidence › Study critique · 26 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Documenting a payment dispute without naming and shaming Replied, post #7 · Sourcing › Payments · 21 Apr 2026 · 13 likes On post #3 — agreed on the reasoning, with one qualification. Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #14 · Compounds › Repair & healing peptides · 20 Apr 2026 · 6 likes post #13 answers the question as asked. The question underneath it is different. The absence of adequately powered published randomised human trials is the central fact…
-
Transporting a vial for a weekend away — a second dataset Replied, post #31 · Practice › Storage & stability · 18 Apr 2026 · 6 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #50 · Practice › Administration · 5 Apr 2026 · 0 likes This follows post #47 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Preprint servers and what screening they do Replied, post #94 · Evidence › Preprints · 19 Mar 2026 · 11 likes On post #90 — agreed on the reasoning, with one qualification. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also…
-
Which fields on a certificate actually matter, ranked Replied, post #16 · Analytics › COA interpretation · 15 Mar 2026 · 0 likes This follows post #13 rather than contradicting it. What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated…
-
Oral versus injected administration claims for BPC-157 Replied, post #9 · Compounds › Repair & healing peptides · 11 Mar 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #18 · Lounge › Introductions · 9 Mar 2026 · 0 likes post #17 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #6 · Compounds › Repair & healing peptides · 7 Mar 2026 · 8 likes This follows post #3 rather than contradicting it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
Research-use-only status: what it means legally and practically Replied, post #11 · Compounds › Other compounds · 6 Mar 2026 · 4 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Waist circumference technique and its repeatability Replied, post #57 · Outcomes › Progress reports · 28 Feb 2026 · 11 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 27 Feb 2026 · 12 likes Picking up post #7: that is the part I would want checked first. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical…
-
Guidelines revision: what changed and why — one year on Replied, post #74 · Meta › Announcements · 23 Feb 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #129 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
The most useful thing you learned here that was not the answer you came for Replied, post #21 · Lounge › Off topic · 16 Feb 2026 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #46 · Outcomes › Progress reports · 13 Feb 2026 · 18 likes Coming back to post #44, because the follow-up matters more than the original answer. Medication changes: escalating dose, or adding or removing other medications, can…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #25 · Practice › Administration · 11 Feb 2026 · 10 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #2 · Practice › Administration · 31 Jan 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #14 · Analytics › COA interpretation · 29 Jan 2026 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #68 · Access › Pricing · 22 Jan 2026 · 21 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #102 · Practice › Side effects · 14 Jan 2026 · 12 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Amylin receptor signalling and satiety — what changed since Replied, post #16 · Pharmacology › Receptor biology · 14 Jan 2026 · 2 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #75 · Clinical › Special populations · 14 Jan 2026 · 2 likes post #74 answers the question as asked. The question underneath it is different. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #3 · Regional › UK & Ireland · 4 Jan 2026 · 14 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #51 · Access › Pricing · 1 Jan 2026 · 18 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #84 · Practice › Side effects · 29 Dec 2025 · 14 likes Coming back to post #82, because the follow-up matters more than the original answer. Recognition and grading: nausea ranges from "noticeable" to "limiting".…
-
Preprint servers and what screening they do Replied, post #7 · Evidence › Preprints · 24 Dec 2025 · 6 likes Worth separating two things that post #3 runs together. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the…
-
How to ask about something you suspect is a bad idea Replied, post #37 · Start Here › How to Ask · 24 Dec 2025 · 5 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #76 · Compounds › Semaglutide · 24 Dec 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Angle of injection and whether 90 degrees is always right Replied, post #69 · Practice › Administration · 21 Dec 2025 · 0 likes post #68 answers the question as asked. The question underneath it is different. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #21 · Safety › Contraindications · 9 Dec 2025 · 10 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #40 · Start Here › How to Ask · 9 Dec 2025 · 8 likes Worth separating two things that post #36 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #31 · Data & Tools › Calculators · 7 Dec 2025 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #8 · Sourcing › Red flags · 6 Dec 2025 · 9 likes post #7 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Tracking a preprint to publication: a worked example Replied, post #54 · Evidence › Preprints · 5 Dec 2025 · 1 like Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #12 · Compounds › Tirzepatide · 1 Dec 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #79 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. Reading a supplier's product description as a marketing document: that is exactly…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #89 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Thyroid function tests during substantial weight change Replied, post #135 · Clinical › Bloodwork · 15 Nov 2025 · 9 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #17 · Research Methods › N-of-1 designs · 6 Nov 2025 · 17 likes post #16 is right about the mechanism and I think understates the practical bit. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
-
Meeting a protein target on a suppressed appetite Replied, post #33 · Nutrition & Training › Protein & intake · 6 Nov 2025 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Oral semaglutide bioavailability and its variability between people Replied, post #13 · Compounds › Oral incretins · 5 Nov 2025 · 5 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
What pooling buys you and what it destroys Replied, post #54 · Evidence › Meta-analyses · 30 Oct 2025 · 23 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #49 · Pharmacology › Receptor biology · 7 Oct 2025 · 16 likes On post #45 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
NHS criteria and how they are applied in practice — the long version Replied, post #9 · Regional › UK & Ireland · 6 Oct 2025 · 23 likes post #8 answers the question as asked. The question underneath it is different. Compounding pharmacies: UK allows compounding under specific conditions when a licensed…
-
Thyroid function tests during substantial weight change Replied, post #83 · Clinical › Bloodwork · 3 Oct 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #15 · Analytics › HPLC & UHPLC · 29 Sep 2025 · 10 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Insurance and replacement policies, compared — the long version Replied, post #17 · Sourcing › Logistics · 19 Sep 2025 · 27 likes post #16 answers the question as asked. The question underneath it is different. Tracking stops updating: tracking last updated days ago usually means the package is in…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #52 · Analytics › Method validation · 15 Sep 2025 · 21 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #86 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #127 · Wellbeing › Mental health · 6 Sep 2025 · 0 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Reading an interaction checker output critically Started this topic · Practice › Interactions · 2 Sep 2025 · 8 likes On the subject in the title: Reading an interaction checker output critically Working notes rather than a conclusion. I have read the maintained page on this and I…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #7 · Compounds › Tirzepatide · 27 Aug 2025 · 25 likes post #6 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #21 · Analytics › Method validation · 25 Aug 2025 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #23 · Compounds › Other compounds · 19 Aug 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Temperature loggers worth the money Replied, post #20 · Devices › Cold chain · 18 Aug 2025 · 19 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #40 · Evidence › Journal club · 15 Aug 2025 · 11 likes post #39 is right about the mechanism and I think understates the practical bit. Session format: read the paper before posting. The discussion is much better when…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #79 · Sourcing › Regulatory · 14 Aug 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
MALDI versus ESI for a quick identity check Started this topic · Analytics › Mass spectrometry · 5 Aug 2025 · 2 likes On the subject in the title: MALDI versus ESI for a quick identity check Working notes rather than a conclusion. Working through the identity arithmetic and I would…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #79 · Compounds › Repair & healing peptides · 24 Jul 2025 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #45 · Meta › Wiki maintenance · 21 Jul 2025 · 3 likes Coming back to post #43, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Repeatability versus intermediate precision Replied, post #109 · Analytics › Method validation · 1 Jul 2025 · 28 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #34 · Data & Tools › Calculators · 25 Jun 2025 · 0 likes Coming back to post #32, because the follow-up matters more than the original answer. Dose equivalence calculator: compounds have different potencies. The calculator is…
-
Repeatability versus intermediate precision Replied, post #12 · Analytics › Method validation · 18 Jun 2025 · 6 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
A claim built entirely on a subgroup analysis Replied, post #44 · Evidence › Study critique · 20 May 2025 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Pregnancy as an absolute contraindication Replied, post #49 · Safety › Contraindications · 18 May 2025 · 0 likes Worth separating two things that post #45 runs together. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #152 · Sourcing › Regulatory · 14 May 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #84 · Sourcing › Independent verification · 12 May 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Follow-up: Documentation that appears only after payment Replied, post #63 · Sourcing › Red flags · 10 May 2025 · 0 likes post #62 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #15 · Nutrition & Training › Protein & intake · 3 May 2025 · 4 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #53 · Compounds › Secretagogues & GH axis · 1 May 2025 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
UK access routes, dated and sourced — a second dataset Replied, post #70 · Regional › UK & Ireland · 28 Apr 2025 · 0 likes Coming back to post #68, because the follow-up matters more than the original answer. Regional variation in NHS: access varies dramatically by region depending on local…
-
Dizziness on standing: the ordinary explanation first Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2025 · 0 likes post #17 answers the question as asked. The question underneath it is different. Constipation and hydration: dehydration makes constipation worse. Increasing fluid…
-
Ipamorelin selectivity claims and where they came from Replied, post #32 · Compounds › Secretagogues & GH axis · 26 Apr 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #13 · Evidence › Journal club · 26 Apr 2025 · 7 likes Picking up post #10: that is the part I would want checked first. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #59 · Practice › Interactions · 24 Apr 2025 · 23 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #5 · Sourcing › Independent verification · 22 Apr 2025 · 0 likes Worth separating two things that the opening post runs together. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #27 · Data & Tools › Calculators · 21 Apr 2025 · 1 like post #26 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #79 · Compounds › Semaglutide · 16 Apr 2025 · 10 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Reflectance and photometric devices: precision in practice Started this topic · Analytics › Home & field testing · 14 Apr 2025 · 48 likes On the subject in the title: Reflectance and photometric devices: precision in practice Working notes rather than a conclusion. I would like to understand what this…
-
Requesting a page: what makes a good request Replied, post #50 · Documentation › Wiki requests · 8 Apr 2025 · 9 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #54 · Practice › Reconstitution · 7 Apr 2025 · 0 likes I read post #52 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Retatrutide dose escalation in the published trials Replied, post #34 · Compounds › Retatrutide · 21 Mar 2025 · 2 likes This follows post #31 rather than contradicting it. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that…
-
When "no data" is the complete and final answer Replied, post #122 · Compounds › Other compounds · 18 Mar 2025 · 0 likes post #121 answers the question as asked. The question underneath it is different. Naming conventions for research peptides cause confusion because suppliers do not…
-
Charge states for a 4 kDa peptide, worked through Replied, post #139 · Analytics › Mass spectrometry · 18 Mar 2025 · 10 likes Picking up post #136: that is the part I would want checked first. Mass accuracy is expressed in parts per million. It is the difference between observed and…
-
Maintainer handover: how it works Replied, post #29 · Meta › Wiki maintenance · 15 Mar 2025 · 31 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #105 · Sourcing › Regulatory · 14 Mar 2025 · 9 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #79 · Pharmacology › Receptor biology · 11 Mar 2025 · 0 likes On post #75 — agreed on the reasoning, with one qualification. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #12 · Access › Pricing · 8 Mar 2025 · 4 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #11 · Sourcing › Regulatory · 27 Feb 2025 · 28 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Distinguishing a deletion sequence by mass alone Replied, post #121 · Analytics › Mass spectrometry · 22 Feb 2025 · 20 likes This follows post #118 rather than contradicting it. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #51 · Pharmacology › Receptor biology · 14 Feb 2025 · 21 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Protein density versus volume when you cannot eat much Replied, post #60 · Nutrition & Training › Protein & intake · 3 Feb 2025 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Multiplicity when you track fifteen variables Replied, post #3 · Research Methods › Statistics · 2 Feb 2025 · 6 likes This follows post #2 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
When to suspect the method rather than the sample Replied, post #74 · Analytics › Method validation · 30 Jan 2025 · 10 likes This follows post #71 rather than contradicting it. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #107 · Compounds › Tirzepatide · 17 Jan 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Recovery when intake is low: what to cut first Replied, post #16 · Nutrition & Training › Resistance training · 10 Jan 2025 · 11 likes On post #12 — agreed on the reasoning, with one qualification. Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding.…
-
A promotion I argued against, and why I lost Replied, post #46 · Documentation › Doc review · 31 Dec 2024 · 2 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #41 · Practice › Interactions · 25 Dec 2024 · 3 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
The topic list is dense — is that deliberate? Replied, post #72 · Meta › Site feedback · 25 Dec 2024 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #37 · Compounds › Semaglutide · 24 Dec 2024 · 21 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #68 · Access › Insurance & coverage · 13 Dec 2024 · 6 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Identical chromatograms across two different lots Replied, post #61 · Sourcing › Red flags · 12 Dec 2024 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Washout with a one-week half-life: the arithmetic Replied, post #81 · Research Methods › N-of-1 designs · 7 Dec 2024 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #45 · Evidence › Journal club · 28 Nov 2024 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Coming back to: When to suspect the method rather than the sample Replied, post #5 · Analytics › Method validation · 28 Nov 2024 · 1 like On the opening post — agreed on the reasoning, with one qualification. Transfer between laboratories: a method can be transferred from one lab to another, but the…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #11 · Compounds › Tirzepatide · 27 Nov 2024 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #38 · Compounds › Semaglutide · 22 Nov 2024 · 12 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
EMA product information as a primary source — does this still hold? Replied, post #56 · Regional › European Union · 16 Nov 2024 · 5 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #16 · Analytics › Impurities & related substances · 21 Oct 2024 · 16 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Promotion criteria, and the one that stops most nominations Replied, post #91 · Documentation › Doc review · 20 Oct 2024 · 1 like This follows post #88 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Hypertension improvement and when medication needs revisiting — a second dataset Started this topic · Clinical › Comorbidities · 6 Oct 2024 · 11 likes Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that.…
-
When a red flag was a misunderstanding, and the retraction Replied, post #21 · Sourcing › Red flags · 22 Sep 2024 · 28 likes Picking up post #18: that is the part I would want checked first. Pricing patterns: unusually low prices for what are otherwise consistent with market rates might…